Endometriosis Trial, Recruiting (NCT04177511)

Endometriosis Trial, Recruiting NCT04177511 Sponsor: Hopital Foch Condition: Endometriosis

Printed from Voxsanity (voxsanity.com.au) — NCT04177511 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Endometriosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are a woman aged 15 years or older
You experience chronic pelvic pain, painful periods, and/or pain during sex
You have been seen and treated by a gynecologist at one of the hospitals or clinics taking part in this study
You have been diagnosed with endometriosis
You are willing and able to sign a written consent form agreeing to take part
You are covered by a health insurance plan

Who may not be able to join:

You have a heart condition or asthma that would make it unsafe to use a specific nerve stimulation device applied to the ear (confirm with trial site)
You are currently pregnant or breastfeeding
You are currently undergoing IVF (in vitro fertilization) treatment
You have another medical condition that requires you to take pain medication on a long-term basis
You have already received ear-based nerve stimulation treatment in the 12 months before joining the study (confirm with trial site)
You are currently in legal custody or under legal guardianship

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Mireille MICHEL-CHERQUI, MD, Hopital Foch, Suresnes

Phone: 0033 1 46 25 29 85

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04177511

Sponsor: Hopital Foch

Phase: Not Applicable

Status: Recruiting

Condition: Endometriosis

Trial contact: 0033 1 46 25 29 85

More information: https://clinicaltrials.gov/study/NCT04177511

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are a woman aged 15 years or older
You experience chronic pelvic pain, painful periods, and/or pain during sex
You have been seen and treated by a gynecologist at one of the hospitals or clinics taking part in this study
You have been diagnosed with endometriosis
You are willing and able to sign a written consent form agreeing to take part
You are covered by a health insurance plan

Who may not be able to join:

You have a heart condition or asthma that would make it unsafe to use a specific nerve stimulation device applied to the ear (confirm with trial site)
You are currently pregnant or breastfeeding
You are currently undergoing IVF (in vitro fertilization) treatment
You have another medical condition that requires you to take pain medication on a long-term basis
You have already received ear-based nerve stimulation treatment in the 12 months before joining the study (confirm with trial site)
You are currently in legal custody or under legal guardianship

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Hopital Foch

Registry

ClinicalTrials.gov

Start date

13 December 2021

Est. completion

28 March 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Change of symptoms related to the pelvic pain

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov